Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
3.295
+0.055 (1.70%)
At close: Sep 4, 2025, 4:00 PM
3.300
+0.005 (0.15%)
After-hours: Sep 4, 2025, 4:10 PM EDT
Health Catalyst Stock Forecast
Stock Price Forecast
The 11 analysts that cover Health Catalyst stock have a consensus rating of "Buy" and an average price target of $5.45, which forecasts a 65.40% increase in the stock price over the next year. The lowest target is $3.50 and the highest is $13.
Price Target: $5.45 (+65.40%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Health Catalyst stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 6 | 5 | 5 | 5 | 5 | 3 |
| Hold | 3 | 4 | 4 | 4 | 4 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $5 | Strong Buy | Maintains | $9 → $5 | +51.75% | Aug 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $3 → $4 | Hold | Maintains | $3 → $4 | +21.40% | Aug 28, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $8 → $4 | Buy → Hold | Downgrades | $8 → $4 | +21.40% | Aug 27, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +82.09% | Aug 11, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $6.5 → $3.5 | Strong Buy → Hold | Downgrades | $6.5 → $3.5 | +6.22% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
323.65M
from 306.58M
Increased by 5.57%
Revenue Next Year
331.15M
from 323.65M
Increased by 2.32%
EPS This Year
0.22
from -1.15
EPS Next Year
0.40
from 0.22
Increased by 79.15%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 351.8M | 387.5M | ||
| Avg | 323.7M | 331.2M | ||
| Low | 303.4M | 292.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 14.7% | 19.7% | ||
| Avg | 5.6% | 2.3% | ||
| Low | -1.0% | -9.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.40 | 0.63 | ||
| Avg | 0.22 | 0.40 | ||
| Low | 0.16 | 0.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 180.7% | ||
| Avg | - | 79.1% | ||
| Low | - | 26.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.